|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stewart C, Ralyea C and Lockwood S:
Ovarian cancer: An integrated review. Semin Oncol Nurs. 35:151–156.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rooth C: Ovarian cancer: Risk factors,
treatment and management. Br J Nurs. 22:S23–S30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Narod S: Can advanced-stage ovarian cancer
be cured? Nat Rev Clin Oncol. 13:255–261. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Crapnell K, Blaesius R, Hastings A, Lennon
DP, Caplan AI and Bruder SP: Growth, differentiation capacity, and
function of mesenchymal stem cells expanded in serum-free medium
developed via combinatorial screening. Exp Cell Res. 319:1409–1418.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mohr A and Zwacka R: The future of
mesenchymal stem cell-based therapeutic approaches for cancer-from
cells to ghosts. Cancer Lett. 414:239–249. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mendt M, Rezvani K and Shpall E:
Mesenchymal stem cell-derived exosomes for clinical use. Bone
Marrow Transplant. 54 (Suppl 2):S789–S792. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tan F, Li X, Wang Z, Li J, Shahzad K and
Zheng J: Clinical applications of stem cell-derived exosomes.
Signal Transduct Target Ther. 9:172024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qiu L, Wang J, Chen M, Chen F and Tu W:
Exosomal microRNA-146a derived from mesenchymal stem cells
increases the sensitivity of ovarian cancer cells to docetaxel and
taxane via a LAMC2-mediated PI3K/Akt axis. Int J Mol Med.
46:609–620. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ono M, Kosaka N, Tominaga N, Yoshioka Y,
Takeshita F, Takahashi RU, Yoshida M, Tsuda H, Tamura K and Ochiya
T: Exosomes from bone marrow mesenchymal stem cells contain a
microRNA that promotes dormancy in metastatic breast cancer cells.
Sci Signal. 7:ra632014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang S, Mo C, Guo S, Zhuang J, Huang B
and Mao X: Human bone marrow mesenchymal stem cells-derived
microRNA-205-containing exosomes impede the progression of prostate
cancer through suppression of RHPN2. J Exp Clin Cancer Res.
38:4952019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kalinkova L, Kajo K, Karhanek M,
Wachsmannova L, Suran P, Zmetakova I and Fridrichova I:
Discriminating miRNA profiles between endometrioid well- and
poorly-differentiated tumours and endometrioid and serous subtypes
of endometrial cancers. Int J Mol Sci. 21:60712020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
de Lima AB, Silva LM, Gonçales NG,
Carvalho MRS, da Silva Filho AL and da Conceição Braga L:
Three-dimensional cellular arrangement in epithelial ovarian cancer
cell lines TOV-21G and SKOV-3 is associated with apoptosis-related
miRNA expression modulation. Cancer Microenviron. 11:85–92. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu J, Zhang X, Huang Y, Zhang Q, Zhou J,
Zhang X and Wang X: miR-200b and miR-200c co-contribute to the
cisplatin sensitivity of ovarian cancer cells by targeting DNA
methyltransferases. Oncol Lett. 17:1453–1460. 2019.PubMed/NCBI
|
|
15
|
Xing Z, Ma WK and Tran EJ: The DDX5/Dbp2
subfamily of DEAD-box RNA helicases. Wiley Interdiscip Rev RNA.
10:e15192019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Z, Caron de Fromentel C, Kim W, Wang
WH, Sun J, Yan B, Utturkar S, Lanman NA, Elzey BD, Yeo Y, et al:
RNA helicase DDX5 modulates sorafenib sensitivity in hepatocellular
carcinoma via the Wnt/β-catenin-ferroptosis axis. Cell Death Dis.
14:7862023. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Du C, Li DQ, Li N, Chen L, Li SS, Yang Y,
Hou MX, Xie MJ and Zheng ZD: DDX5 promotes gastric cancer cell
proliferation in vitro and in vivo through mTOR signaling pathway.
Sci Rep. 7:428762017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ye X: Confluence analysis of multiple
omics on platinum resistance of ovarian cancer. Eur J Gynaecol
Oncol. 36:514–519. 2015.PubMed/NCBI
|
|
19
|
Xu CM, Chen LX, Gao F, Zhu MF, Dai Y, Xu Y
and Qian WX: MiR-431 suppresses proliferation and metastasis of
lung cancer via down-regulating DDX5. Eur Rev Med Pharmacol Sci.
23:699–707. 2019.PubMed/NCBI
|
|
20
|
Mallmann-Gottschalk N, Sax Y, Kimmig R,
Lang S and Brandau S: EGFR-specific tyrosine kinase inhibitor
modifies NK cell-mediated antitumoral activity against ovarian
cancer cells. Int J Mol Sci. 20:46932019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mahmoudian-Sani MR, Forouzanfar F,
Asgharzade S and Ghorbani N: Overexpression of MiR-183/96/182
triggers retina-like fate in human bone marrow-derived mesenchymal
stem cells (hBMSCs) in culture. J Ophthalmol. 2019:24543622019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li B, Luan S, Chen J, Zhou Y, Wang T, Li
Z, Fu Y, Zhai A and Bi C: The MSC-derived exosomal lncRNA H19
promotes wound healing in diabetic foot ulcers by upregulating PTEN
via MicroRNA-152-3p. Mol Ther Nucleic Acids. 19:814–826. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li W, Han Y, Zhao Z, Ji X, Wang X, Jin J,
Wang Q, Guo X, Cheng Z, Lu M, et al: Oral mucosal mesenchymal stem
cell-derived exosomes: A potential therapeutic target in oral
premalignant lesions. Int J Oncol. 54:1567–1578. 2019.PubMed/NCBI
|
|
24
|
Sun P, Fan X, Hu X, Fu X, Wei Q and Zang
Y: circPCNX and pecanex promote hepatocellular carcinoma cell
viability by inhibiting miR-506. Cancer Manag Res. 11:10957–10967.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang F, Chen Y, Ren S, Li Z, Sun K, Xing
Y, Zhu Y and Piao D: Cyclovirobuxine D inhibits colorectal cancer
tumorigenesis via the CTHRC1-AKT/ERK-Snail signaling pathway. Int J
Oncol. 57:183–196. 2020.PubMed/NCBI
|
|
26
|
Wang S, Su X, Xu M, Xiao X, Li X, Li H,
Keating A and Zhao RC: Exosomes secreted by mesenchymal
stromal/stem cell-derived adipocytes promote breast cancer cell
growth via activation of Hippo signaling pathway. Stem Cell Res
Ther. 10:1172019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun H, Wang H and Wang X, Aoki Y and Wang
X, Yang Y, Cheng X, Wang Z and Wang X: Aurora-A/SOX8/FOXK1
signaling axis promotes chemoresistance via suppression of cell
senescence and induction of glucose metabolism in ovarian cancer
organoids and cells. Theranostics. 10:6928–6945. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu X, Zhao J, Ruan Y, Sun L, Xu C and
Jiang H: Sialyltransferase ST3GAL1 promotes cell migration,
invasion, and TGF-β1-induced EMT and confers paclitaxel resistance
in ovarian cancer. Cell Death Dis. 9:11022018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Z, Wang P, Cao L, Li F, Duan S, Yuan
G, Xiao L, Guo L, Yin H, Xie D, et al: Long intergenic non-coding
RNA 01121 promotes breast cancer cell proliferation, migration, and
invasion via the miR-150-5p/HMGA2 axis. Cancer Manag Res.
11:10859–10870. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li N, Cui T, Guo W, Wang D and Mao L:
MiR-155-5p accelerates the metastasis of cervical cancer cell via
targeting TP53INP1. Onco Targets Ther. 12:3181–3196. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu SC, Cao YH, Chen LB, Kang R, Huang ZX
and Lu XS: BMSC-derived exosomal lncRNA PTENP1 suppresses the
malignant phenotypes of bladder cancer by upregulating SCARA5
expression. Cancer Biol Ther. 23:1–13. 2022. View Article : Google Scholar
|
|
32
|
Xiu C, Zheng H, Jiang M, Li J, Zhou Y, Mu
L and Liu W: MSCs-derived miR-150-5p-expressing exosomes promote
skin wound healing by activating PI3K/AKT pathway through PTEN. Int
J Stem Cells. 15:359–371. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Furuta T, Miyaki S, Ishitobi H, Ogura T,
Kato Y, Kamei N, Miyado K, Higashi Y and Ochi M: Mesenchymal stem
cell-derived exosomes promote fracture healing in a mouse model.
Stem Cells Transl Med. 5:1620–1630. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang S, Ma Y, Hu X, Zheng Y and Chen X:
Targeting PRMT5/Akt signalling axis prevents human lung cancer cell
growth. J Cell Mol Med. 23:1333–1342. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Reza AMMT, Choi YJ, Yasuda H and Kim JH:
Human adipose mesenchymal stem cell-derived exosomal-miRNAs are
critical factors for inducing anti-proliferation signalling to
A2780 and SKOV-3 ovarian cancer cells. Sci Rep. 6:384982016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hua S, Quan Y, Zhan M, Liao H, Li Y and Lu
L: miR-125b-5p inhibits cell proliferation, migration, and invasion
in hepatocellular carcinoma via targeting TXNRD1. Cancer Cell Int.
19:2032019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wieser V, Tsibulak I, Reimer DU, Zeimet
AG, Fiegl H, Hackl H and Marth C: An angiogenic tumor phenotype
predicts poor prognosis in ovarian cancer. Gynecol Oncol.
170:290–299. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
de Araujo Farias V, O'Valle F,
Serrano-Saenz S, Anderson P, Andrés E, López-Peñalver J, Tovar I,
Nieto A, Santos A, Martín F, et al: Exosomes derived from
mesenchymal stem cells enhance radiotherapy-induced cell death in
tumor and metastatic tumor foci. Mol Cancer. 17:1222018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xu H, Zhao G, Zhang Y, Jiang H, Wang W,
Zhao D, Hong J, Yu H and Qi L: Mesenchymal stem cell-derived
exosomal microRNA-133b suppresses glioma progression via
Wnt/β-catenin signaling pathway by targeting EZH2. Stem Cell Res
Ther. 10:3812019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shang S, Wang J, Chen S, Tian R, Zeng H,
Wang L, Xia M, Zhu H and Zuo C: Exosomal miRNA-1231 derived from
bone marrow mesenchymal stem cells inhibits the activity of
pancreatic cancer. Cancer Med. 8:7728–7740. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
He Z, Li W, Zheng T, Liu D and Zhao S:
Human umbilical cord mesenchymal stem cells-derived exosomes
deliver microRNA-375 to downregulate ENAH and thus retard
esophageal squamous cell carcinoma progression. J Exp Clin Cancer
Res. 39:1402020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shi H, Li K, Feng J, Liu G, Feng Y and
Zhang X: LncRNA-DANCR interferes with miR-125b-5p/HK2 axis to
desensitize colon cancer cells to cisplatin vis activating
anaerobic glycolysis. Front Oncol. 10:10342020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu S, Chen Q and Wang Y: MiR-125b-5p
suppresses the bladder cancer progression via targeting HK2 and
suppressing PI3K/AKT pathway. Hum Cell. 33:185–194. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li Y, Wang Y, Fan H, Zhang Z and Li N:
miR-125b-5p inhibits breast cancer cell proliferation, migration
and invasion by targeting KIAA1522. Biochem Biophys Res Commun.
504:277–282. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yang D, Zhan M, Chen T, Chen W, Zhang Y,
Xu S, Yan J, Huang Q and Wang J: miR-125b-5p enhances chemotherapy
sensitivity to cisplatin by down-regulating Bcl2 in gallbladder
cancer. Sci Rep. 7:431092017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mei LL, Wang WJ, Qiu YT, Xie XF, Bai J and
Shi ZZ: miR-125b-5p functions as a tumor suppressor gene partially
by regulating HMGA2 in esophageal squamous cell carcinoma. PLoS
One. 12:e01856362017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang M, Weng W, Zhang Q, Wu Y, Ni S, Tan
C, Xu M, Sun H, Liu C, Wei P and Du X: The lncRNA NEAT1 activates
Wnt/β-catenin signaling and promotes colorectal cancer progression
via interacting with DDX5. J Hematol Oncol. 11:1132018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Xing Z, Russon MP, Utturkar SM and Tran
EJ: The RNA helicase DDX5 supports mitochondrial function in small
cell lung cancer. J Biol Chem. 295:8988–8998. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu C, Wang L, Jiang Q, Zhang J, Zhu L,
Lin L, Jiang H, Lin D, Xiao Y, Fang W and Guo S: Hepatoma-derived
growth factor and DDX5 promote carcinogenesis and progression of
endometrial cancer by activating β-catenin. Front Oncol. 9:2112019.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang Z, Luo Z, Zhou L, Li X, Jiang T and
Fu E: DDX5 promotes proliferation and tumorigenesis of
non-small-cell lung cancer cells by activating β-catenin signaling
pathway. Cancer Sci. 106:1303–1312. 2015. View Article : Google Scholar : PubMed/NCBI
|
